Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Nov 20, 2023
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
Policy Notices
- Special Emphasis Notice: AHRQ Announces Interest in Health Services Research to Improve Healthcare for Persons Living with Disabilities
(NOT-HS-24-004)
Agency for Healthcare Research and Quality
- Reminder to AHRQ Grantees that FY2019 Funds will Expire on September 30, 2024
(NOT-HS-24-005)
Agency for Healthcare Research and Quality
- Clarification of Implementation of the NIH SBIR and STTR Foreign Disclosure Pre-award and Post-Award Requirements
(NOT-OD-24-029)
National Institutes of Health
General Notices
- Notice of Informational Webinar: Intervention Research to Improve Native American Health: Whats New with PAR-23-298, PAR-23-285, PAR-23-299"
(NOT-DA-23-045)
National Institute on Drug Abuse
- Notice of Informational Webinar for the National Institute of General Medical Sciences Predoctoral Basic Biomedical Sciences Research Training Program (T32)
(NOT-GM-24-011)
National Institute of General Medical Sciences
- Notice of Pre-Application Webinar for Ethical, Legal and Social Implications (ELSI) Research: PAR-23-293 (R01 Clinical Trial Optional), PAR-23-294 (R21 Clinical Trial Optional) and PAR-23-295 (R03 Clinical Trial Optional)
(NOT-HG-24-010)
National Human Genome Research Institute
- Notice of termination of the NINDS Postdoctoral Mentored Career Development Award K01 (PAR-23-143 and PAR-23-142)
(NOT-NS-24-031)
National Institute of Neurological Disorders and Stroke
- Findings of Research Misconduct
(NOT-OD-24-028)
Office of the Director, NIH
- Extension of Application Receipt Dates for PAR-18-799 NIOSH Mentored Research Scientist Development Award (K01)
(NOT-OH-24-003)
National Institute for Occupational Safety and Health
- Extension of Application Receipt Dates for PAR-18-812 NIOSH Occupational Safety and Health Research (R01)
(NOT-OH-24-004)
National Institute for Occupational Safety and Health
- Extension of Application Receipt Dates for PAR-18-797 NIOSH Small Research Grant Program (R03)
(NOT-OH-24-005)
National Institute for Occupational Safety and Health
- Extension of Application Receipt Dates for PAR-18-798 NIOSH Exploratory/Developmental Grant Program (R21)
(NOT-OH-24-006)
National Institute for Occupational Safety and Health
- Request for Information (RFI): BRAIN Initiative: Brain Behavior Quantification and Synchronization: Guidance for Opportunities in Development of Sensor Technology Hubs
(NOT-MH-24-125)
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Neurological Disorders and Stroke
Notice of Changes to Funding Opportunities
- Notice of Early Expiration of PAR-23-174 "Aging Research Dissertation Awards to Promote Diversity (R36 Clinical Trial Not Allowed)"
(NOT-AG-23-064)
National Institute on Aging
- Notice of Change to Key Dates Listed in PAR-23-053 and PAR-23-054
(NOT-AG-23-071)
National Institute on Aging
- Notice to Clarify Eligibility Requirements of Program Directors/Principal Investigators (PDs/PIs) in PAR-24-039 Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)
(NOT-CA-24-009)
National Cancer Institute
- Notice of Extension of the Expiration Date for PAR-21-294 "Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)"
(NOT-CA-24-013)
National Cancer Institute
- Notice to Expire NOT-ES-22-003 "Notice of Special Interest (NOSI): KC Donnelly Externship (Admin Supp Clinical Trial Not Allowed)
(NOT-ES-24-001)
National Institute of Environmental Health Sciences
- Notice of Change to Foreign Institution Eligibility in PAR-23-241 "IDeA Clinical & Translational Research Network (CTR-N) Award (P50 - Clinical Trial Optional)"
(NOT-GM-24-009)
National Institute of General Medical Sciences
- Notice of NHGRI Participation in PAR-23-309, Health and Health Care Disparities Among Persons Living with Disabilities (R01 - Clinical Trials Optional)
(NOT-HG-24-007)
National Human Genome Research Institute
- Notice of Correction to Expiration Date for PAR-24-063 "Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)"
(NOT-NS-24-030)
National Institute of Neurological Disorders and Stroke
Notices of Intent to Publish
- Notice of Intent to Publish a Funding Opportunity Announcement for Cancer Adoptive Cellular Therapy Network (Can-ACT) for Pediatric Cancers (UG3/UH3 Clinical Trial Required)
(NOT-CA-24-010)
National Cancer Institute
Requests for Proposal
- Pre-Solicitation Notice: Humoral Immunology Core Laboratory for AIDS Vaccine Research, RFP: 75N93023R00012
(NOT-AI-24-005)
National Institute of Allergy and Infectious Diseases
Notices of Special Interest
- Notice of Special Interest (NOSI): Telehealth for People and Families Living with Alzheimer's Disease (AD) and AD-Related Dementias (ADRD)
(NOT-AG-23-060)
National Institute on Aging
- Notice of Special Interest: Leveraging Existing and Accessible Datasets for Implementation Research Strategies and Testing - LEAD FIRST
(NOT-HL-23-120)
National Heart, Lung, and Blood Institute
- Notice of Special Interest (NOSI): Administrative Supplements to Support Addiction Science and Related Neuroscience Pilot Research Projects at NIMHD-Funded Research Centers in Minority Institutions (RCMI)
(NOT-MD-23-019)
National Institute on Minority Health and Health Disparities
National Institute on Drug Abuse
- Notice of Special Interest (NOSI): Advance Data Science Approaches Through Secondary Data Analysis to Reveal Scientific Insights of COVID-19 Testing Technologies (R21)
(NOT-OD-24-026)
Office of the Director, NIH
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Library of Medicine
Office of Research on Women's Health
Funding Opportunities
- Initiative for Maximizing Student Development (IMSD) (T32)
(PAR-24-031)
National Institute of General Medical Sciences - Graduate Research Training Initiative for Student Enhancement (G-RISE) (T32)
(PAR-24-032)
National Institute of General Medical Sciences - Aging Research Dissertation Awards to Promote Diversity (R36 Clinical Trial Not Allowed)
(PAR-24-052)
National Institute on Aging - Nursing Research Education Program in Firearm Injury Prevention Research: Short Courses (R25 Independent Clinical Trial Not Allowed)
(PAR-24-061)
National Institute of Nursing Research
Office of Behavioral and Social Sciences Research - Adolescent Overdose Prevention and SUD Treatment Initiative (R21 - Clinical Trial Not Allowed)
(RFA-DA-25-030)
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism - Adolescent Overdose Prevention and SUD Treatment Initiative (R34 - Clinical Trial Optional)
(RFA-DA-25-031)
National Institute on Drug Abuse - Integrating Machine Learning with Computational Fluid Dynamics Models of Orally Inhaled Drug Products (U01) Clinical Trials Not Allowed
(RFA-FD-24-005)
Food and Drug Administration - Developing PBPK Model-Based Mechanistic IVIVCs for Long Acting Injectable Suspensions and Implants (U01) Clinical Trial Optional
(RFA-FD-24-006)
Food and Drug Administration - Evaluating the Cutaneous Pharmacokinetics of Topical Drug Products Using Pharmacokinetic Tomography (U01 Clinical Trial Required)
(RFA-FD-24-008)
Food and Drug Administration - Improving Predictability of Food-Drug and Drug-Drug Interaction Risks by Utilizing In Vitro Simulated Gastrointestinal Dissolution Model for High-Risk Oral Drug Products (U01) Clinical Trial Optional
(RFA-FD-24-009)
Food and Drug Administration
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 313-335-2123, or email Ann Ricketts or Lynn Hudachek.